Leave a little sharper than you arrived.
News, calculators, learning and daily puzzles — pick any one and leave a little further along.
Today’s puzzle
Latest News

Rethinking myasthenia gravis treatment: less prednisone, more targeted therapy
The era of high-dose, long-term prednisone for generalized myasthenia gravis (gMG) is giving way to smarter, targeted approaches. At a recent clinical forum, neurologists discussed how FcRn inhibitors, complement C5 inhibitors, and emerging CAR-T therapies are reshaping treatment sequencing. The key message: aggressive steroid use carries real risks, and newer agents offer faster, safer alternatives.
Every 3 vs. every 6 weeks: Pembrolizumab dosing frequency doesn't change key outcomes in kidney cancer

Older age doesn't raise overall immune side effect risk in kidney cancer combo therapy — but complications still climb

Cabozantinib + nivolumab beats sunitinib in kidney cancer with bone metastases — even at 5 years

Everything on Curie.MD
Get Curie’s Weekly Dose
What changed in clinical practice, policy, and coverage, and what it means for your patients.
Subscribe free Free. Weekly. Unsubscribe anytime.